Hong Kong’s AMTA Settles Quickly On Upsher-Smith’s Qudexy XR
Market For Generic Qudexy XR Opened More Than Three Years Ago
A Hatch-Waxman case in Delaware stemming from AMTA Labs’ proposed generic version of Upsher-Smith’s Qudexy XR (topiramate) extended-release capsules has closed with a swift settlement.
